Page last updated: 2024-08-23

pirfenidone and Airflow Obstruction, Chronic

pirfenidone has been researched along with Airflow Obstruction, Chronic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elia, D; Harari, S; Humbert, M1
Maeda, S1
Araya, J; Asano, H; Fujita, Y; Hara, H; Hashimoto, M; Hosaka, Y; Ichikawa, A; Ishikawa, T; Ito, S; Kadota, T; Kaneko, Y; Kobayashi, K; Kuwano, K; Minagawa, S; Morikawa, T; Nakayama, K; Nishimura, SL; Numata, T; Odaka, M; Saito, N; Sato, N; Tsubouchi, K; Utsumi, H; Wakui, H; Yamashita, M; Yanagisawa, H; Yoshida, M1
Kang, S1
Case, N; Chapman, RW; Crawley, Y; Egan, RW; Fine, J; Hey, JA; Kreutner, W; Kung, T; Minnicozzi, M; Spond, J; Wang, P1

Reviews

2 review(s) available for pirfenidone and Airflow Obstruction, Chronic

ArticleYear
Pulmonary Hypertension in Parenchymal Lung Diseases: Any Future for New Therapies?
    Chest, 2018, Volume: 153, Issue:1

    Topics: Antihypertensive Agents; Chronic Disease; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endpoint Determination; Epoprostenol; Forecasting; Guanylate Cyclase; Humans; Hypertension, Pulmonary; Indoles; Lung Diseases, Interstitial; Phosphodiesterase 5 Inhibitors; Pilot Projects; Protein-Tyrosine Kinases; Pulmonary Disease, Chronic Obstructive; Pyridones

2018
[Perioperative Management of Patients with Pulmonary Comorbidities Undergoing Lung Resection].
    Kyobu geka. The Japanese journal of thoracic surgery, 2017, Volume: 70, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Comorbidity; Glucocorticoids; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Methylprednisolone; Perioperative Care; Pneumonectomy; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pyridones; Respiratory Insufficiency

2017

Other Studies

3 other study(ies) available for pirfenidone and Airflow Obstruction, Chronic

ArticleYear
PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis.
    Autophagy, 2019, Volume: 15, Issue:3

    Topics: Animals; Cell Cycle Proteins; Cell Line; Cellular Senescence; Cigarette Smoking; Disease Models, Animal; Epithelial Cells; Humans; Lung; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron; Mitochondria; Mitophagy; Nuclear Proteins; Protein Kinases; PTEN Phosphohydrolase; Pulmonary Disease, Chronic Obstructive; Pyridones; Reactive Oxygen Species; Ubiquitin-Protein Ligases

2019
2014 American Thoracic Society International Conference.
    The Lancet. Respiratory medicine, 2014, Volume: 2, Issue:7

    Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Asthma; Congresses as Topic; Eosinophilia; Expectorants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Idiopathic Pulmonary Fibrosis; Indoles; Lung Neoplasms; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridones; Respiratory Distress Syndrome

2014
Inhibition of experimental acute pulmonary inflammation by pirfenidone.
    Pulmonary pharmacology & therapeutics, 2003, Volume: 16, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Guinea Pigs; Humans; Interleukin-6; Lipopolysaccharides; Male; Mice; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pyridones; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

2003